Market Briefing

Weekly Watched Assets — 2026-07-15

10 high-conviction US stocks identified from monthly sentiment analysis.

LNG — Cheniere Energy, Inc.

1W +3.9% | 1M +9.8% | 3M +3.5% | YTD +34.6%

"multi-bagger"

Thesis: The investment thesis centers on a severe mispricing amid record fundamentals and a permanent global LNG supply shortfall, with the destruction of Qatari capacity acting as a high-impact, near-term catalyst. Institutional options activity and aggressive accumulation underscore a structural re-rating with multi-bagger potential. Conviction: 96% (high)

ADSK — Autodesk, Inc.

1W -3.0% | 1M +3.8% | 3M -14.0% | YTD -28.2%

"FactSet names ADSK the most undervalued stock in the S&P 500 with 68% upside potential"

Thesis: Anchored by FactSet naming ADSK the most undervalued stock in the S&P 500 with 68% upside, the thesis is amplified by the FTC clearance of the MaintainX acquisition, catalyzing a powerful re-rating in a high-conviction SaaS play. The asymmetric upside is time-sensitive and institutionally validated. Conviction: 96% (high)

ZTO — ZTO Express (Cayman) Inc.

1W +3.7% | 1M +5.3% | 3M -4.2% | YTD +13.8%

"a strategic masterstroke with high potential to ignite a re-rating"

Thesis: The $1.5 billion fully funded share repurchase is a rare, aggressive capital allocation move that signals deep undervaluation and acts as a direct catalyst for a structural re-rating. This strategic masterstroke is drawing institutional attention in an underperforming sector. Conviction: 96% (high)

HII — Huntington Ingalls Industries, Inc.

1W -3.3% | 1M -5.9% | 3M -29.4% | YTD -19.4%

"asymmetric risk/reward"

Thesis: A transformative contract win and the July 2026 manned-unmanned teaming unveiling provide long-term revenue visibility and a structural shift into high-margin logistics, creating asymmetric risk/reward. The DCF-derived $452 fair value highlights a deep valuation gap warranting aggressive accumulation. Conviction: 96% (high)

LDOS — Leidos Holdings, Inc.

1W -1.9% | 1M -12.5% | 3M -32.8% | YTD -41.6%

"one of the most egregious market mispricings in the S&P 500"

Thesis: Despite a selloff after earnings, operational excellence persists, creating one of the most egregious mispricings in the S&P 500. A sentiment shift is imminent, offering high asymmetric risk/reward for contrarian investors positioned ahead of the re-rating. Conviction: 96% (high)

MKC — McCormick & Company, Incorporated

1W +1.2% | 1M +8.9% | 3M +0.9% | YTD -20.0%

"high-conviction, institutional-grade deal"

Thesis: The potential Berkshire Hathaway $45B preferred investment in the Unilever reverse Morris Trust merger is a high-conviction, structural re-rating catalyst. This institutional-grade deal could unlock massive value if execution is validated, justifying aggressive accumulation. Conviction: 96% (high)

BEP — Brookfield Renewable Partners L.P.

1W -2.5% | 1M -6.4% | 3M -8.3% | YTD +17.6%

"material, government-backed catalyst"

Thesis: The $17.5 billion nuclear financing and Boralex acquisition represent material, government-backed catalysts driving immediate structural acceleration. The deep value inflection is supported by aggressive accumulation amid market underappreciation. Conviction: 95% (high)

NOC — Northrop Grumman Corporation

1W -3.7% | 1M -3.9% | 3M -21.8% | YTD -9.0%

"dangerous disconnect between fundamentals and market pricing"

Thesis: With the 2027 DFARS rare earth deadline and B-21 production ramp, NOC is poised for a contrarian recovery driven by long-term defense tailwinds. The dangerous disconnect between fundamentals and pricing creates a deep value inflection with asymmetric risk/reward. Conviction: 95% (high)

J — Jacobs Solutions Inc.

1W -0.8% | 1M +1.8% | 3M +1.9% | YTD -4.0%

"classic case of 'slow growth' mindset mispricing a transformation leader in a high-growth inflection era"

Thesis: A record $27B backlog and 1.4x book-to-bill reveal a stark disconnect between slow-growth perception and transformational execution. The shift toward high-margin, visible growth offers a deep value opportunity as sentiment corrects. Conviction: 95% (high)

DG — Dollar General Corporation

1W +4.1% | 1M +5.2% | 3M -0.7% | YTD -10.9%

"transformative move to build a digitally enabled convenience network"

Thesis: DG's $352M in Q1 capex and 1,370+ store remodels signal a transformative pivot to a digitally integrated convenience network, with the 200-day breakout signaling institutional interest. While momentum is improving, macro risks in retail create higher execution uncertainty. Conviction: 94% (high)

Weekly Watched Assets — 2026-07-05

14 high-conviction US stocks identified from monthly sentiment analysis.

TEAM — Atlassian Corp.

1W +12.3% | 1M -23.1% | 3M +22.8% | YTD -45.8%

"structural re-rating"

Thesis: The investment thesis centers on a deep value inflection driven by explosive earnings revisions, a Zacks Rank #1, and extreme undervaluation amid forced selling, creating a time-sensitive window for structural re-rating. Near-term catalysts including AI monetization and index reclassification provide clear upside visibility. Conviction: 98% (high)

GH — Guardant Health Inc. Common Stock

1W +17.5% | 1M +29.1% | 3M +79.0% | YTD +65.1%

"seismic leap"

Thesis: GH is positioned at a transformative regulatory and commercial inflection point, with national coverage determination and UnitedHealthcare's 100M+ patient expansion serving as high-impact catalysts. The stock's momentum reflects early institutional accumulation ahead of potential market-destabilizing growth. Conviction: 96% (high)

TTAN — ServiceTitan Inc. Class A Common Stock

1W +23.5% | 1M +4.4% | 3M +24.4% | YTD -22.9%

"one of the most extreme dislocations in the tech sector"

Thesis: TTAN trades at a 40.1% discount to intrinsic value despite a dominant AI-enabled platform and growing transaction data moat. Monetization of 'Karen' AI and real revenue traction create a rare non-disruptable platform narrative with asymmetric risk/reward. Conviction: 97% (high)

IX — ORIX Corporation

1W +1.5% | 1M +0.6% | 3M +30.1% | YTD +32.5%

"transformative capital return move that materially boosts per-share value"

Thesis: A JPY 250 billion buyback with share cancellation acts as a powerful near-term catalyst, signaling strong fundamental acceleration and U.S. integration. The deep value inflection is supported by extraordinary earnings revision momentum and institutional confidence. Conviction: 96% (high)

ROP — Roper Technologies, Inc.

1W +9.6% | 1M +8.2% | 3M +2.0% | YTD -16.0%

"one of the most powerful sentiment indicators in the sector this week"

Thesis: ROP presents a rare contrarian opportunity in the software/industrial space, driven by high-conviction insider activity, extreme undervaluation, and imminent regulatory catalysts. The potential for rapid re-rating is amplified by its immunology franchise's transformative potential. Conviction: 96% (high)

BSX — Boston Scientific Corporation

1W +2.1% | 1M -5.3% | 3M -28.1% | YTD -52.3%

"catastrophic disconnect between fundamentals and market sentiment"

Thesis: Despite a severe FDA recall overhang, BSX shows strong fundamentals and near-term catalysts including Penumbra's Thunderbolt clearance and MiRus SIEGEL TAVR development. The catastrophic disconnect between sentiment and fundamentals creates a multi-bagger contrarian recovery case. Conviction: 95% (high)

ELV — Elevance Health, Inc.

1W +7.9% | 1M +7.9% | 3M +39.5% | YTD +19.2%

"structural re-rating"

Thesis: Seth Klarman’s $373M investment and the CMS lawsuit serve as pivotal catalysts for a structural re-rating, validating ELV's strategic shift. Momentum is strong, and the deep value inflection supports a high-conviction, multi-bagger recovery thesis. Conviction: 95% (high)

NYT — New York Times Company (The) Common Stock

1W +7.7% | 1M -1.9% | 3M -13.8% | YTD +6.3%

"central beneficiary of AI-driven attention economy monetization"

Thesis: Berkshire Hathaway’s near-tripling of its stake provides institutional validation, while the landmark lawsuit against OpenAI and Microsoft unlocks transformative AI licensing revenue potential. The thesis combines low-risk accumulation with high-return optionality. Conviction: 95% (high)

PCT — PureCycle Technologies, Inc.

1W -3.7% | 1M -40.8% | 3M +40.4% | YTD -15.0%

"giving PCT a near-monopoly in a high-growth segment"

Thesis: PCT holds a near-monopoly in food-grade #5 plastic recycling, with NJDEP certification acting as a key commercial catalyst. The market’s indiscriminate selling has created a dangerous disconnect between execution and perception, offering contrarian upside. Conviction: 95% (high)

NBIX — Neurocrine Biosciences Inc. Common Stock

1W +6.1% | 1M +12.5% | 3M +32.4% | YTD +23.9%

"paradigm shift in pediatric endocrine therapy"

Thesis: NBIX is leveraging groundbreaking clinical results to build a rare sustainable revenue moat in pediatric endocrinology and rare diseases. The transformative foothold in congenital adrenal hyperplasia provides a clear path to blockbuster potential and investor confidence inflection. Conviction: 94% (high)

BWXT — BWX Technologies Inc. Common Stock

1W -6.7% | 1M +2.0% | 3M -11.0% | YTD +5.3%

"paradigm shift in BWXT’s business model"

Thesis: BWXT is undergoing a paradigm shift from parts supplier to technology enabler, fueled by the $1.4B DOE contract and mPower™ licensing, creating a high-margin, royalty-backed SMR growth engine. The deep valuation disconnect suggests significant re-rating potential. Conviction: 94% (high)

CTSH — Cognizant Technology Solutions Corporation

1W +7.2% | 1M -23.9% | 3M -32.4% | YTD -47.7%

"a credible move positioning CTSH as a first-mover in sovereign AI infrastructure"

Thesis: CTSH is emerging as a foundational enabler in the agentic AI era, with strategic partnerships and sovereign AI infrastructure positioning. Pzena’s stake increase during the selloff signals contrarian conviction in undervaluation and future re-rating. Conviction: 93% (high)

ZTO — ZTO Express (Cayman) Inc.

1W +5.9% | 1M +2.2% | 3M -6.0% | YTD +9.3%

"creating a high-conviction long-term value and growth opportunity"

Thesis: ZTO combines operational outperformance with a fully funded $1.5B buyback, creating a high-conviction long-term value opportunity despite sentiment weakness. The PEG of 0.84 highlights a severe fundamental-market disconnect. Conviction: 95% (high)

VST — Vistra Corp.

1W -10.0% | 1M -4.2% | 3M +0.1% | YTD -8.3%

"unquestioned infrastructure backbone of the AI era"

Thesis: VST is the unquestioned infrastructure backbone of the AI era, with transformative PPAs and exceptional ROE execution. Despite deep undervaluation, recent negative price momentum and lack of near-term momentum indicators reduce near-term conviction. Conviction: 92% (high)

Weekly Watched Assets — 2026-06-25

10 high-conviction US stocks identified from monthly sentiment analysis.

NTES — NetEase Inc. ADR

1W -2.7% | 1M +1.5% | 3M +7.6% | YTD -19.0%

"a rare high-conviction opportunity where fundamentals are outpacing sentiment, making any failure to meet expectations potentially catastrophic"

Thesis: NetEase presents a rare confluence of deep value, high-quality growth, and a near-term catalyst through its participation in DeepSeek's $7.4B funding round, which could trigger a structural re-rating. The market is underpricing both its fundamental strength and strategic AI positioning, creating asymmetric risk/reward. Conviction: 97% (high)

ROP — Roper Technologies, Inc.

1W +0.5% | 1M +1.4% | 3M -5.3% | YTD -23.5%

"one of the most compelling individual conviction signals in the software/industrial space"

Thesis: Roper combines exceptional capital allocation with a $3 billion buyback and insider buying, signaling strong internal confidence. The company is deeply undervalued despite durable cash flows, with mounting contrarian signals pointing to an imminent re-rating. Conviction: 97% (high)

IFF — International Flavors & Fragrances Inc.

1W +0.2% | 1M +1.3% | 3M +7.1% | YTD +12.7%

"deep value inflection"

Thesis: IFF is poised for a structural re-rating following the completion of its $4.3 billion divestiture, which unlocks significant margin of safety and enables aggressive accumulation. Insider buying and a major upgrade confirm a deep value inflection is underway. Conviction: 96% (high)

IX — ORIX Corporation

1W -3.2% | 1M -1.3% | 3M +29.4% | YTD +30.0%

"unmodeled Kioxia stake sale catalyst is critical: if Toshiba proceeds, ORIX’s earnings and valuation could rise sharply"

Thesis: ORIX offers a rare deep value opportunity in financials, driven by a JPY 250 billion buyback with share cancellations and a potential unmodeled catalyst from the Kioxia stake sale. These factors create significant per-share value accretion and asymmetric upside. Conviction: 96% (high)

J — Jacobs Solutions Inc.

1W -0.7% | 1M +6.4% | 3M -5.5% | YTD -9.3%

"fundamentally reshaping its strategic trajectory"

Thesis: Jacobs is fundamentally reshaping its trajectory with a record $26 billion+ backlog and near-monopoly access to key government programs. Despite operational excellence, it remains aggressively undervalued, creating explosive commercial momentum and a clear path to re-rating. Conviction: 94% (high)

RELX — RELX PLC

1W -2.7% | 1M -5.6% | 3M -1.0% | YTD -20.2%

"a stark market disconnect exposing a dangerous mispricing and systemic overreaction to narrative risk, not substance"

Thesis: RELX is experiencing a severe market disconnect despite being a core enabler of AI through its partnership with Anthropic. The mispricing creates a rare long-term compounding opportunity with asymmetric risk/reward and strong contrarian tailwinds. Conviction: 95% (high)

PTC — PTC Inc.

1W -3.4% | 1M -23.8% | 3M -21.6% | YTD -33.6%

"deeply undervalued business with rare profitability and scalability"

Thesis: PTC is transforming legacy systems into intelligent digital engineering platforms, supported by a $2 billion buyback and strong AI integration. Despite transient sentiment drag, its profitability and scalability are deeply undervalued, signaling a potential inflection. Conviction: 95% (high)

VG — Venture Global Inc. Class A common stock

1W -4.9% | 1M -23.9% | 3M -37.4% | YTD +49.7%

"breakthrough in U.S. LNG export momentum"

Thesis: Venture Global has achieved a breakthrough in U.S. LNG export momentum with landmark deals and a $2.25B refinancing, providing exceptional revenue visibility. The market has yet to price in this institutional-grade credibility and infrastructure scaling. Conviction: 95% (high)

VRSN — VeriSign, Inc.

1W -4.8% | 1M -18.7% | 3M +0.8% | YTD +5.5%

"high-conviction bet on a sustained move above $290"

Thesis: VeriSign is positioned for a structural re-rating around the $290 options expiration, supported by concentrated institutional call buying. Persistent underreaction to fundamentals creates a time-sensitive, high-conviction setup despite near-term volatility. Conviction: 95% (high)

ONDS — Ondas Holdings Inc

1W -15.8% | 1M -15.2% | 3M -18.6% | YTD -30.3%

"a defining inflection point for the company"

Thesis: Ondas is at a defining inflection point with U.S. Army contract integration and Lockheed Martin’s Sanctum™ adoption, but faces significant execution risk and negative momentum. While the long-term vision is compelling, near-term uncertainty dampens risk/reward clarity. Conviction: 94% (high)

Weekly Watched Assets — 2026-06-15

8 high-conviction US stocks identified from monthly sentiment analysis.

AES — The AES Corporation

1W +0.1% | 1M +1.7% | 3M +4.7% | YTD +1.5%

"ironclad arbitrage case with minimal execution risk"

Thesis: The investment thesis is centered on a near-certain, low-risk arbitrage opportunity with a $15.00 all-cash acquisition offer, trading below offer price with minimal execution risk. This represents one of the clearest risk/reward profiles with a defined catalyst and time horizon. Conviction: 96% (high)

NTES — NetEase Inc. ADR

1W +5.3% | 1M +5.6% | 3M +8.8% | YTD -13.4%

"high-conviction, asymmetric opportunity"

Thesis: A high-conviction, asymmetric opportunity driven by AI integration and a strategic stake in DeepSeek, creating a clear catalyst for re-rating amid substantial undervaluation. The thesis is tightly coupled with tangible, near-term value realization potential. Conviction: 98% (high)

RNR — RenaissanceRe Holdings Ltd.

1W +4.3% | 1M +3.8% | 3M +2.4% | YTD +10.7%

"significant mispricing risk and high-conviction contrarian opportunity"

Thesis: Exhibits a compelling contrarian case with severe undervaluation relative to earnings power and capital efficiency, supported by a structural re-rating catalyst from improved underwriting performance and capital returns. Momentum is building, and risk/reward is clearly skewed to the upside. Conviction: 98% (high)

ROP — Roper Technologies, Inc.

1W +0.8% | 1M +5.9% | 3M -4.3% | YTD -22.7%

"transformative capital allocation strategy"

Thesis: A high-conviction value bet anchored in a transformative $3 billion buyback, signaling deep undervaluation and strong internal confidence in future cash flows. The thesis is reinforced by a rare combination of capital allocation clarity and long-term structural advantages. Conviction: 96% (high)

BKNG — Booking Holdings Inc.

1W -0.5% | 1M +6.7% | 3M -2.5% | YTD -22.2%

"a powerful leap beyond traditional booking platforms into AI-native travel intelligence"

Thesis: Despite negative YTD performance, the thesis highlights a rare sentiment-driven mispricing amid strong operational resilience and a powerful AI-driven transformation via Penny launch and board-level strategic shifts. Catalysts are specific but longer-term, with re-rating potential delayed by macro sentiment. Conviction: 96% (high)

SUZ — Suzano S.A.

1W +0.6% | 1M -4.0% | 3M -17.8% | YTD -13.5%

"structural redefinition of the company"

Thesis: Presents a high-conviction, asymmetrical opportunity driven by a structural redefinition through a transformative joint venture with Kimberly-Clark, yet trading at extreme discount levels. Catalyst is sentiment re-rating, which is specific but dependent on market perception shifts. Conviction: 96% (high)

HAWK — HawkEye 360

1W -5.5% | 1M -29.3% | 3M n/a | YTD -30.0%

"a make-or-break inflection point for HAWK’s long-term viability"

Thesis: A speculative but high-upside inflection play hinging on the Block 3 satellite deployment as a make-or-break catalyst. While the valuation disconnect and asymmetric risk/reward are clearly articulated, the thesis carries high execution risk and weak recent momentum, increasing uncertainty. Conviction: 96% (high)

MDGL — Madrigal Pharmaceuticals Inc. Common Stock

1W -1.3% | 1M -7.3% | 3M +8.1% | YTD -19.0%

"powerful asymmetric opportunity"

Thesis: Represents a high-risk, high-reward biotech play dependent on F4c trial outcomes, with explosive commercial potential but significant binary risk. Despite strong conviction language, lack of positive momentum and high volatility reduce near-term appeal despite the asymmetric profile. Conviction: 95% (high)

Weekly Watched Assets — 2026-06-05

15 high-conviction US stocks identified from monthly sentiment analysis.

MTCH — Match Group, Inc.

1W -4.4% | 1M -7.7% | 3M +11.7% | YTD +10.8%

"presenting a high-conviction, asymmetric opportunity"

Thesis: The CCI ruling serves as a near-term, high-likelihood catalyst enabling massive structural margin expansion, creating a rare asymmetric opportunity with deep undervaluation relative to DCF. The investment thesis is tightly coupled with a clear, binary catalyst and aggressive accumulation language. Conviction: 97% (high)

ROP — Roper Technologies, Inc.

1W +3.8% | 1M -6.9% | 3M -9.1% | YTD -23.4%

"nearly 38% below fair value"

Thesis: With a nearly 38% undervaluation to fair value and multiple catalysts including transformative regulatory approval and aggressive capital return, ROP presents a high-conviction, structural re-rating opportunity. The thesis is backed by exceptional fundamentals and institutional endorsement. Conviction: 98% (high)

NTRA — Natera Inc. Common Stock

1W +3.8% | 1M +7.4% | 3M +12.7% | YTD -3.0%

"paradigm-shifting event"

Thesis: FDA approval of Signatera CDx is a paradigm-shifting, reimbursement-enabling catalyst that validates NTRA's shift from speculative growth to earnings-based confidence. Extreme valuation disconnect and aggressive price target upgrades signal substantial unpriced upside. Conviction: 96% (high)

PODD — Insulet Corporation

1W +2.6% | 1M -12.6% | 3M -39.2% | YTD -48.2%

"multi-bagger"

Thesis: Despite a severe drawdown, PODD shows deep institutional faith and a clear path to recovery via FDA approval for Omnipod 6 enabled by Libre 3 Plus integration, framing it as a contrarian multi-bagger opportunity with significant margin of safety. Conviction: 96% (high)

WDAY — Workday Inc.

1W +13.8% | 1M +14.8% | 3M +0.5% | YTD -28.1%

"quantum leap in trust and governance"

Thesis: ASOR certification and AI leadership represent a quantum leap in governance and trust, exposing a dangerous disconnect between fundamentals and price. The structural re-rating case is time-sensitive and supported by strong momentum in the past month. Conviction: 96% (high)

DHR — Danaher Corporation

1W +3.3% | 1M +6.9% | 3M -7.4% | YTD -18.8%

"aggressive move into AI-native bioprocessing (Genedata Vico) and precision oncology ecosystems gives it a first-mover advantage"

Thesis: The Masimo acquisition is central to DHR’s long-term AI-driven biopharma narrative and highlights a severe mispricing despite operational resilience and science-tech convergence. The 33.1x P/E belies stagnation fears amid underlying innovation. Conviction: 95% (high)

A — Agilent Technologies, Inc.

1W +2.2% | 1M +17.7% | 3M +17.4% | YTD +0.7%

"transformative shift toward an AI-powered, recurring-revenue intelligent laboratory ecosystem with outsized long-term growth potential"

Thesis: Agilent is transitioning into an AI-powered, recurring-revenue intelligent lab ecosystem with a structural moat in precision oncology, driven by FDA milestones and pent-up investor demand. The re-rating potential is amplified by execution confidence. Conviction: 95% (high)

BEPC — Brookfield Renewable Corporation Brookfield Renewable Corporation Class A Subordinate Voting Shares

1W -1.6% | 1M +6.9% | 3M -2.4% | YTD -0.8%

"asymmetric risk/reward"

Thesis: The Microsoft 10.5 GW deal provides a concrete near-term catalyst for a deep value inflection, with aggressive accumulation signaling institutional conviction in a structural re-rating despite short-term underperformance. Conviction: 95% (high)

EXR — Extra Space Storage Inc.

1W +0.0% | 1M +4.3% | 3M +0.0% | YTD +12.7%

"redefine the self-storage sector’s technological future"

Thesis: The appointment of RJ Pittman signals a transformational AI-driven pivot that could redefine the self-storage sector, creating a high-conviction, deep value inflection with a significant margin of safety. Conviction: 96% (high)

NTRS — Northern Trust Corporation

1W +2.8% | 1M +7.1% | 3M +21.3% | YTD +24.9%

"highlighting a clear market mispricing of its capital efficiency and sustainable growth profile"

Thesis: NTRS is undergoing a decisive shift into quant and smart beta asset management, with a clear market mispricing of its capital efficiency and growth profile. Strong 3-month and YTD performance validate the emerging re-rating. Conviction: 94% (high)

WPC — W. P. Carey Inc.

1W -0.3% | 1M +1.1% | 3M +3.3% | YTD +15.6%

"glaring mispricing"

Thesis: The $1.1B GardenCore sale-leaseback is a strategic inflection point that demonstrates unmatched capital deployment and earnings visibility, with institutional validation and aggressive accumulation underscoring a glaring mispricing. Conviction: 95% (high)

RMD — ResMed Inc.

1W -4.5% | 1M -6.2% | 3M -23.7% | YTD -20.2%

"profound valuation disconnect"

Thesis: Despite an unexplained 8.81% decline amid sector strength, RMD’s pivot into digital therapeutics via Noctrix and ŪRA partnership reveals a profound valuation disconnect and transformative clinical pipeline potential. Conviction: 96% (high)

XOM — Exxon Mobil Corporation

1W +3.5% | 1M -1.2% | 3M +1.5% | YTD +25.6%

"transforming Guyana into a self-sustaining, high-margin growth engine"

Thesis: Exxon’s transformation in Guyana and governance improvements are de-risking long-standing overhangs, positioning as investor skepticism sets up a powerful re-rating catalyst amid energy security tailwinds. Conviction: 95% (high)

SEIC — SEI Investments Company Common Stock

1W -0.0% | 1M -2.4% | 3M +8.0% | YTD +6.7%

"a compelling mispricing opportunity if execution holds"

Thesis: SEI’s launch of SEHAX and LEND ETFs and the Stratos acquisition mark a strategic inflection toward active management, disrupting low-cost ETF models—though execution risk remains a caveat despite compelling mispricing. Conviction: 95% (high)

TS — Tenaris S.A.

1W +6.5% | 1M +2.7% | 3M +23.7% | YTD +66.8%

"presents a rare opportunity for value investors"

Thesis: Despite strong fundamentals and capital returns, Tenaris experienced a post-earnings sell-off, creating a rare value opportunity. However, the thesis lacks depth compared to peers, with fewer specific growth catalysts beyond market mispricing. Conviction: 92% (high)

Weekly Watched Assets — 2026-05-25

20 high-conviction US stocks identified from monthly sentiment analysis.

VG — Venture Global Inc. Class A common stock

1W -2.8% | 1M +12.1% | 3M +42.9% | YTD +96.7%

"this is the single most important development in VG’s history"

Thesis: The investment thesis centers on a structural re-rating driven by CP2 FID and 84% revenue contract coverage, with a clear near-term catalyst on May 12, 2026, and a +9.36% Earnings ESP signaling strong upside potential. The stock is already exhibiting explosive momentum, up 96.7% YTD, confirming early re-rating. Conviction: 96% (high)

IX — ORIX Corporation

1W +6.0% | 1M +27.3% | 3M +9.9% | YTD +31.7%

"This is not just a value play; it’s a capital efficiency renaissance"

Thesis: A transformative JPY 250 billion buyback and strategic pivot to high-ROE private equity and real assets create a capital efficiency renaissance and a time-sensitive re-rating opportunity. Momentum is strong, with a 27.3% one-month gain and 31.7% YTD return, validating the thesis. Conviction: 96% (high)

SIRI — Sirius XM Holdings Inc.

1W +11.8% | 1M +4.0% | 3M +38.6% | YTD +44.1%

"a transformative catalyst poised to redefine its revenue model and catalyze a stock re-rating"

Thesis: The YouTube partnership represents a transformative revenue model shift, supported by unprecedented call option activity pointing to institutional conviction. The stock has surged 38.6% over three months and 44.1% YTD, reflecting accelerating momentum ahead of the 2026 catalyst. Conviction: 96% (high)

ABEV — Ambev S.A.

1W +4.2% | 1M +6.3% | 3M +4.2% | YTD +29.6%

"high-conviction, execution-driven market leader"

Thesis: A high-conviction, execution-driven play on a structural re-rating fueled by the 2026 FIFA World Cup and shifting consumer behavior, with aggressive accumulation already underway. Strong momentum, up 29.6% YTD and 6.3% in one month, supports near-term upside. Conviction: 98% (high)

BBVA — Banco Bilbao Vizcaya Argentaria, S.A.

1W +2.2% | 1M +0.4% | 3M -1.9% | YTD -3.8%

"fundamentally shifts market perception from a resilient but underappreciated bank to a credit-quality leader—potentially triggering a long-overdue re-rating"

Thesis: A contrarian deep value inflection driven by Fitch’s A+ upgrade and AI-enabled credit leadership creates a rare asymmetric opportunity. Despite flat recent performance, the structural re-rating case is strong and time-sensitive, with institutional conviction building. Conviction: 96% (high)

NTRA — Natera Inc. Common Stock

1W +9.0% | 1M -2.2% | 3M -4.2% | YTD -11.2%

"a catalyst with potential to re-rate the stock 50%+"

Thesis: An FDA approval catalyst and pivotal trial data ahead create a defining inflection point with potential for 50%+ re-rating. Recent 9% weekly momentum suggests positioning ahead of the event, reinforcing the asymmetric risk/reward profile. Conviction: 96% (high)

INVH — Invitation Homes Inc.

1W +4.9% | 1M +9.8% | 3M +17.2% | YTD +7.0%

"paradigm shift for SFR REITs, enabling indefinite ownership, organic growth, and sustained scale"

Thesis: The removal of the 7-year forced-sale mandate enables indefinite ownership and organic growth, creating a paradigm shift for SFR REITs. The stock is already re-rating, up 17.2% over three months, with strong 9.8% monthly momentum. Conviction: 96% (high)

NTRS — Northern Trust Corporation

1W +2.4% | 1M -0.0% | 3M +16.6% | YTD +21.1%

"a re-rating is not just plausible—it is inevitable"

Thesis: A deep value inflection driven by earnings disconnect and transformation under new quantitative leadership supports an inevitable re-rating. Strong 16.6% three-month and 21.1% YTD returns reflect early momentum. Conviction: 96% (high)

PEG — Public Service Enterprise Group Incorporated

1W +4.0% | 1M +1.3% | 3M -6.3% | YTD -1.0%

"PEG’s announcement of new nuclear development at Salem is a game-changing catalyst"

Thesis: The Salem nuclear development is a game-changing catalyst positioning PEG as a first-mover in baseload decarbonization, with structural re-rating potential. Recent 4% weekly gain and positive momentum signal early recognition. Conviction: 96% (high)

WRB — W. R. Berkley Corporation

1W +1.6% | 1M +0.1% | 3M -4.9% | YTD -2.5%

"a near-term re-rating is due"

Thesis: A severe mispricing relative to fundamentals and strong underwriting performance create a near-term re-rating opportunity with asymmetric risk/reward. The stock shows early signs of momentum recovery despite muted recent returns. Conviction: 96% (high)

OKLO — Oklo Inc. Class A common stock

1W +5.8% | 1M -9.0% | 3M +3.2% | YTD -15.3%

"multi-bagger"

Thesis: A high-conviction, multi-bagger opportunity centered on the July 4, 2026 criticality target, with regulatory, supply, and demand catalysts aligning. Recent 5.8% weekly gain shows speculative buildup ahead of the event. Conviction: 95% (high)

IOT — Samsara Inc.

1W +5.4% | 1M -2.8% | 3M +16.3% | YTD -8.2%

"high-conviction"

Thesis: The June 4, 2026 earnings report is a defined inflection point for a structural re-rating, with AI-driven operational efficiency already embedded. Strong 16.3% three-month return and 5.4% weekly momentum signal early positioning. Conviction: 95% (high)

CASS — Cass Information Systems Inc

1W -0.0% | 1M -5.9% | 3M +2.8% | YTD +13.2%

"positions CASS as the de facto 'central nervous system' of North American freight"

Thesis: FMCSA reforms are creating a permanent competitive moat, transforming CASS into the 'central nervous system' of North American freight with scalable, recurring revenue. Recent 13.2% YTD gain reflects growing recognition. Conviction: 95% (high)

RL — Ralph Lauren Corporation

1W +15.6% | 1M +0.7% | 3M -1.6% | YTD +4.5%

"expect explosive upside"

Thesis: A quiet transformation is underway, with the market mispricing future growth as stagnation. Explosive 15.6% weekly momentum suggests a re-rating has begun ahead of earnings outperformance. Conviction: 95% (high)

BR — Broadridge Financial Solutions, Inc.

1W +3.3% | 1M -6.3% | 3M -14.5% | YTD -31.4%

"This divergence creates a powerful contrarian alpha opportunity"

Thesis: AI is already embedded in production across 40+ clients, creating a powerful contrarian alpha opportunity as the market overlooks operational execution. Despite negative momentum, the catalyst is tangible and near-term. Conviction: 95% (high)

RMD — ResMed Inc.

1W +3.1% | 1M -6.0% | 3M -19.5% | YTD -14.6%

"high-conviction contrarian bet if execution delivers"

Thesis: A high-conviction contrarian bet on digital health execution, with a critical disconnect between value and perception. Recent underperformance (-19.5% 3m) increases risk, but re-rating potential is high if initiatives gain traction. Conviction: 95% (high)

SWK — Stanley Black & Decker, Inc.

1W +1.8% | 1M +1.0% | 3M -15.9% | YTD +1.1%

"rare opportunity for alpha via fundamental mispricing"

Thesis: A 31% EPS beat and transformative capital allocation have been ignored by the market, creating a rare alpha opportunity. Despite strong fundamentals, momentum remains weak, increasing near-term risk. Conviction: 95% (high)

TPR — Tapestry, Inc.

1W +7.1% | 1M -5.2% | 3M -11.6% | YTD +7.6%

"a re-rating could lift the stock to $200+"

Thesis: An AI-driven transformation and undervalued cash flow create a structural re-rating opportunity, with potential to reach $200+. However, recent underperformance and high-risk framing suggest uncertainty around execution. Conviction: 95% (high)

TXT — Textron Inc.

1W +3.5% | 1M +2.6% | 3M -8.8% | YTD +5.5%

"high-conviction growth story"

Thesis: Segment separation and USDA contract validation represent a transformative shift into mission-essential services, with potential for re-rating or short squeeze. Modest momentum supports early accumulation. Conviction: 95% (high)

BWXT — BWX Technologies Inc. Common Stock

1W -0.8% | 1M -7.3% | 3M -1.4% | YTD +11.9%

"high-conviction"

Thesis: A systemically important opportunity with near-term catalysts in PCG acquisition and Navy contracts, but recent underperformance (-7.3% 1m) suggests execution risk. Thesis remains strong, but momentum lags. Conviction: 98% (high)

Weekly Watched Assets — 2026-05-15

10 high-conviction US stocks identified from monthly sentiment analysis.

STM — STMicroelectronics N.V.

1W +15.2% | 1M +57.4% | 3M +92.1% | YTD +135.9%

"foundational player in two of the most transformative tech trends of the decade"

Thesis: STM presents a high-conviction opportunity driven by its pivotal role in two transformative tech trends—AI data centers and LEO satellites—with aggressive institutional accumulation signaling a structural re-rating. Recent price momentum is exceptionally strong, with 1m and 3m returns of 57.41% and 92.1%, indicating the market is already repricing its growth trajectory. Conviction: 96% (high)

GEN — Gen Digital Inc.

1W +14.8% | 1M +22.6% | 3M -1.1% | YTD -10.6%

"a dangerous anomaly that signals entrenched investor skepticism despite irreversible momentum"

Thesis: GEN combines explosive recent momentum (22.58% over 1 month) with a clear, high-conviction contrarian thesis centered on Microsoft integration as a near-term catalyst. The market's skepticism persists despite accelerating execution, creating a rare asymmetric risk/reward setup with inflection potential. Conviction: 97% (high)

NBIX — Neurocrine Biosciences Inc. Common Stock

1W +6.3% | 1M +21.6% | 3M +29.2% | YTD +13.1%

"transformative clinical result"

Thesis: NBIX offers a deeply undervalued profile with a 66.7% DCF-implied upside, catalyzed by transformative clinical results in the CAH trial, providing a clear, high-impact catalyst. Strong upward momentum across all timeframes confirms growing investor recognition of its asymmetric risk/reward. Conviction: 95% (high)

CI — The Cigna Group

1W +3.8% | 1M +8.2% | 3M +3.1% | YTD +6.2%

"Chris Davis’s massive stake accumulation—up 196.73% in Q1—represents a rare, high-conviction vote of confidence from a top-tier value investor"

Thesis: Chris Davis's 196.73% stake increase is a rare, high-conviction signal of deep undervaluation and asymmetric upside, suggesting a critical disconnect between fundamentals and price. Momentum is positive across all periods, especially strong in the last month (8.19%), supporting revaluation potential. Conviction: 95% (high)

URBN — Urban Outfitters Inc

1W -2.3% | 1M +4.5% | 3M +0.8% | YTD -8.7%

"Scott Black’s massive 328.99% stake increase in URBN represents a rare, high-conviction vote of confidence from a respected value investor in a struggling retail sector"

Thesis: Scott Black’s 328.99% stake increase is a powerful contrarian signal in a challenged sector, implying a 24.4% upside and marking a deep value inflection. While momentum is modest, the clarity of the catalyst and valuation gap support strong risk/reward asymmetry. Conviction: 96% (high)

FDS — FactSet Research Systems Inc.

1W -10.8% | 1M -10.6% | 3M -0.5% | YTD -29.5%

"platform-level transformation expected to redefine how asset managers operate"

Thesis: FDS is poised for a structural re-rating due to its J.P. Morgan partnership, which validates hidden infrastructure value and platform-level transformation. Despite strong conviction and a 36% margin of safety, weak price momentum (-29.49% YTD) increases near-term risk. Conviction: 95% (high)

PTC — PTC Inc.

1W -5.3% | 1M +4.6% | 3M -7.3% | YTD -17.8%

"multi-bagger"

Thesis: PTC exhibits a deep value inflection with aggressive accumulation and a $2 billion buyback acting as a near-term catalyst, yet price momentum remains negative over 3m and YTD. The thesis is strong but faces headwinds from broader market skepticism despite solid fundamentals. Conviction: 96% (high)

SPHR — Sphere Entertainment

1W -1.4% | 1M +1.0% | 3M +16.5% | YTD +43.0%

"transforms SPHR’s vision from speculative hype into a proven, scalable business model with undeniable market dominance"

Thesis: SPHR’s recent results validate its technology-driven entertainment model as scalable and commercially dominant, marking a shift from speculation to proof. Momentum is solid YTD (42.99%) but near-term weakness suggests consolidation ahead of next catalyst. Conviction: 95% (high)

INTU — Intuit Inc.

1W -7.0% | 1M +3.1% | 3M -4.7% | YTD -39.6%

"AI-driven transformation is reinforcing Intuit’s long-term moat"

Thesis: INTU’s AI-driven moat expansion and FedNow certification offer a structural re-rating path, but steep YTD decline (-39.61%) reflects execution risk and sentiment fragility. Catalyst is time-sensitive around earnings, increasing near-term volatility. Conviction: 95% (high)

MSI — Motorola Solutions, Inc.

1W -7.8% | 1M -9.3% | 3M -11.7% | YTD +5.1%

"persistent undervaluation, despite clear structural advantages, presents a compelling contrarian case for long-term investors"

Thesis: MSI presents a contrarian case based on structural advantages and undervaluation, supported by Aristotle Capital’s entry, but persistent price declines across all periods (-11.7% over 3m) suggest momentum may lag. Catalyst is implied but less specific, increasing holding period risk. Conviction: 95% (high)

Weekly Watched Assets — 2026-05-05

7 high-conviction US stocks identified from monthly sentiment analysis.

GWRE — Guidewire Software Inc. Common Stock

1W +5.1% | 1M -4.8% | 3M +3.4% | YTD -23.5%

"structural re-rating"

Thesis: The investment thesis centers on a clear fundamental-market disconnect with a named near-term catalyst—ProNavigator adoption inflection—driving a structural re-rating. Institutional-grade conviction language and a high margin of safety support a contrarian recovery with asymmetric risk/reward. Conviction: 98% (high)

GEN — Gen Digital Inc.

1W +3.2% | 1M +3.9% | 3M -17.1% | YTD -24.3%

"a landmark strategic partnership that positions GEN as foundational trust infrastructure for the AI economy"

Thesis: A high-stakes, time-sensitive catalyst—the May 7, 2026 earnings release—frames GEN's potential re-rating as a pivotal credibility test amid extreme skepticism, with a compelling narrative of foundational AI trust infrastructure and 43% undervaluation. The thesis combines deep value, narrative shift, and binary event risk. Conviction: 95% (high)

INTU — Intuit Inc.

1W +4.4% | 1M -3.4% | 3M -16.2% | YTD -35.0%

"AI-driven transformation is reinforcing Intuit’s long-term moat"

Thesis: Intuit's AI-driven transformation and FedNow certification create a structural moat expansion with a clear path to re-rating if Q3 results deliver. Despite severe YTD underperformance, the combination of deep undervaluation and infrastructure-level positioning supports strong risk/reward. Conviction: 96% (high)

JKHY — Jack Henry & Associates, Inc.

1W +1.0% | 1M -3.1% | 3M -14.6% | YTD -14.2%

"high-conviction endorsement from a sophisticated investor"

Thesis: Backed by a high-conviction endorsement from Riverwater Partners and tied to the May 5 earnings catalyst, JKHY is framed as a contrarian recovery with structural re-rating potential. The thesis emphasizes aggressive accumulation at a deep value inflection point with asymmetric upside. Conviction: 96% (high)

SE — Sea Limited

1W -0.1% | 1M +3.8% | 3M -24.8% | YTD -35.0%

"a rare convergence of explosive growth and deep undervaluation"

Thesis: Sea presents a rare mix of explosive growth and deep undervaluation, with Q1 2026 earnings acting as a potential catalyst for sentiment reversal. However, concerns over Latin America expansion and unit economics introduce execution risk that clouds the risk/reward clarity. Conviction: 94% (high)

SYF — Synchrony Financial

1W -3.3% | 1M +8.5% | 3M +1.4% | YTD -11.9%

"the $6.5B buyback and dividend hike are not just financial actions—they are strategic statements of"

Thesis: The $6.5B buyback and dividend hike are framed as strategic confidence signals pointing to a structural shift toward AI-integrated consumer finance, with a Q3 2026 catalyst. While the thesis implies a re-rating, financial services cyclicality and sentiment headwinds moderate conviction. Conviction: 94% (high)

URBN — Urban Outfitters Inc

1W -5.8% | 1M +5.6% | 3M -6.1% | YTD -9.5%

"rare, high-conviction vote of confidence"

Thesis: A pivotal inflection in investor perception is implied by Scott Black's stake increase and compelling valuation relative to 47.3% EPS growth, suggesting a re-rating is overdue. However, weak near-term momentum and retail sector volatility reduce conviction despite strong fundamentals. Conviction: 96% (high)

Weekly Watched Assets — 2026-04-25

15 high-conviction US stocks identified from monthly sentiment analysis.

HLI — Houlihan Lokey Inc. Class A Common Stock

1W -2.8% | 1M +11.4% | 3M -14.8% | YTD -10.1%

"massive re-rating potential"

Thesis: A high-conviction contrarian opportunity driven by severe market mispricing and a specific near-term catalyst: the May 6, 2026 earnings release. The company's structural transformation and exceptional earnings growth are underappreciated, creating massive re-rating potential. Conviction: 96% (high)

GPN — Global Payments Inc.

1W -6.4% | 1M -4.2% | 3M -9.6% | YTD -10.0%

"69.5% discount to intrinsic value"

Thesis: A rare confluence of government trust, digital leadership, and a 69.5% discount to intrinsic value creates an asymmetric risk/reward setup. The May 6, 2026 earnings event is a high-stakes catalyst that could trigger a structural re-rating. Conviction: 96% (high)

IOT — Samsara Inc.

1W -2.2% | 1M -5.9% | 3M -6.7% | YTD -11.7%

"deep value inflection"

Thesis: A deep value inflection driven by factory-integrated AI and OEM exclusivity with International Motors' PDI program rollout. The combination of contrarian recovery and structural re-rating provides clear catalyst timing and margin of safety. Conviction: 96% (high)

JKHY — Jack Henry & Associates, Inc.

1W -1.9% | 1M -4.0% | 3M -18.1% | YTD -14.9%

"structural re-rating"

Thesis: A rare opportunity in an undervalued, resilient fintech infrastructure provider, with a $1B credit facility and Riverwater's institutional positioning acting as near-term catalysts. The disconnect between fundamentals and sentiment supports aggressive accumulation. Conviction: 96% (high)

NTRA — Natera Inc. Common Stock

1W -2.2% | 1M +3.2% | 3M -15.7% | YTD -11.0%

"contrarian recovery"

Thesis: A contrarian recovery play with a landmark patent win enabling 30% ongoing royalties, redefining its valuation trajectory. The clinical, legal, and financial inflection points create a multi-bagger opportunity with high conviction. Conviction: 95% (high)

TEAM — Atlassian Corp.

1W +6.9% | 1M +7.7% | 3M -45.7% | YTD -53.8%

"deep value inflection"

Thesis: A deep value inflection amid record fundamentals and extreme stock depreciation, with the April 30, 2026 earnings as a pivotal re-rating catalyst. The asymmetric risk/reward profile stands out in a volatile tech landscape. Conviction: 96% (high)

GLPI — Gaming and Leisure Properties Inc. Common Stock

1W -0.9% | 1M +3.7% | 3M +5.9% | YTD +8.2%

"game-changing structural safeguard that removes a systemic risk to GLPI’s lease security"

Thesis: A credit-protected REIT de-risked by a replacement parent guarantee, removing systemic lease risk and unlocking re-rating momentum. With 53.3% upside implied by DCF, this is a time-sensitive, high-upside opportunity. Conviction: 95% (high)

OVV — Ovintiv Inc.

1W +5.5% | 1M -7.3% | 3M +36.6% | YTD +38.4%

"structural re-rating"

Thesis: A structural re-rating driven by a $3B share repurchase and debt reduction, capitalizing on temporary mispricing amid strong execution. The valuation gap and top-tier upgrades support aggressive accumulation. Conviction: 95% (high)

PAA — Plains All American Pipeline L.P. Common Units representing Limited Partner Interests

1W +2.3% | 1M -2.9% | 3M +14.5% | YTD +20.7%

"profound market mispricing that represents a high-conviction opportunity"

Thesis: A 60% undervaluation to DCF and a near-term catalyst in the Competition Bureau's Keyera divestiture review resolution create a high-conviction, multi-bagger opportunity with significant margin of safety. Conviction: 95% (high)

SPG — Simon Property Group, Inc.

1W -2.5% | 1M +10.8% | 3M +10.2% | YTD +10.6%

"a rare confluence of undervaluation and upward momentum"

Thesis: A rare confluence of undervaluation and upward momentum, with Q1 2026 earnings as a pivotal re-rating event. Institutional buying and a transformative acquisition reinforce long-term strategic positioning. Conviction: 95% (high)

SNN — Smith & Nephew plc

1W -8.1% | 1M -1.2% | 3M -3.8% | YTD -2.5%

"pivotal clinical milestone"

Thesis: A pivotal clinical milestone and the January 2027 CPT code catalyst could unlock rapid revenue expansion and reimbursement adoption. Despite innovation leadership, entrenched skepticism maintains a compelling valuation gap. Conviction: 96% (high)

VEEV — Veeva Systems Inc.

1W -4.1% | 1M -9.5% | 3M -27.4% | YTD -26.6%

"Michael Burry’s $200M+ entry with a 3.5% stake in VEEV—a high-conviction, contrarian move"

Thesis: Michael Burry’s $200M+ stake signals elite confidence in Veeva’s structural moats and regulatory defensibility. This contrarian move may catalyze broader market re-rating despite current headwinds. Conviction: 95% (high)

INTU — Intuit Inc.

1W +0.7% | 1M -7.0% | 3M -29.6% | YTD -36.8%

"Morgan Stanley upgraded Intuit to a Top Pick with a $580 price target (58% upside)"

Thesis: Morgan Stanley’s Top Pick upgrade and $580 price target highlight a dangerous disconnect between fundamentals and price. FedNow certification could act as a game-changing catalyst for financial infrastructure leadership. Conviction: 95% (high)

WY — Weyerhaeuser Company

1W -0.6% | 1M +5.8% | 3M -5.3% | YTD +6.1%

"high-conviction contrarian bet"

Thesis: A contrarian bet supported by Baron Capital’s accumulation and Trump’s $51M bond purchase, with Q1 2026 earnings and a +38.46% Zacks ESP as a near-term catalyst. The structural re-rating case is strong but faces sector headwinds. Conviction: 96% (high)

SHOP — Shopify Inc.

1W -4.1% | 1M +6.3% | 3M -8.8% | YTD -20.0%

"a defining moment that shifts investor perception from skepticism to confidence"

Thesis: A strategic shift toward algorithmic commerce and improved platform stickiness is redefining investor perception. However, weak momentum and high valuation expectations make it the weakest among these high-conviction names. Conviction: 96% (high)

Weekly Watched Assets — 2026-04-15

4 high-conviction US stocks identified from monthly sentiment analysis.

TECH — Bio-Techne Corporation

1W +9.0% | 1M +15.4% | 3M -11.5% | YTD -1.5%

"creating a rare, high-conviction buying opportunity at a severe valuation dislocation"

Thesis: The investment thesis centers on a severe valuation dislocation driven by irrational market fear post-earnings, with a clear catalyst in the completed divestiture enabling a fundamental re-rating. Strong operational fundamentals and innovation are mispriced, creating a time-sensitive, high-conviction buying opportunity with asymmetric risk/reward. Conviction: 98% (high)

BILI — Bilibili

1W +8.8% | 1M -0.8% | 3M -20.4% | YTD -5.2%

"premier alpha play in the China tech recovery story"

Thesis: Bilibili represents a premier contrarian play in the China tech recovery, trading at a nearly 50% discount to fair value with catalysts including AI-driven monetization and earnings validation. Synchronized institutional upgrades and insider buying support an imminent structural re-rating. Conviction: 98% (high)

CSL — Carlisle Companies Incorporated

1W +7.9% | 1M +4.8% | 3M +0.6% | YTD +9.2%

"Goldman Sachs added Carlisle Companies (CSL) to its Conviction List with a $442 price target and Buy rating"

Thesis: Goldman Sachs' addition to its Conviction List underscores a compelling risk/reward profile driven by Vision 2030 execution and a severe market disconnect. The structural re-rating thesis is supported by strong institutional conviction and positive momentum across multiple time horizons. Conviction: 95% (high)

SNAP — Snap Inc.

1W +16.7% | 1M +22.8% | 3M -29.9% | YTD -31.1%

"creates a rare high-conviction contrarian opportunity for long-term investors betting on a narrative reset"

Thesis: Snap offers a high-conviction contrarian opportunity fueled by extreme undervaluation and a potential narrative reset, despite ongoing regulatory pressures. While recent momentum is strong, the catalyst remains less tangible compared to peers, introducing higher uncertainty around timing and execution. Conviction: 95% (high)